TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Completed

PLASMA Chile (PLASMA Chile)

Prospective, multicenter, observational cohort study to collect data on Chilean patients diagnosed with Heart Failure with reduced ejection fraction, their treatments, and their progress in a real-world environment. Additional objectives wi

Concepción, Chile+5 moreView details
WithdrawnN/A

Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea

The study objectives are to demonstrate the ease and safety of bilateral cervically implanted phrenic nerve stimulators for Central Sleep Apnea in patients with Heart Failure. To demonstrate the efficacy, both in the short and long term, of

Brighton, Massachusetts, United StatesView details
CompletedN/A

Biomarkers Correlation With Volemia

The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admis

Le Krémilin Bicêtre, Île-de-France Region, FranceView details
UnknownPhase 2

Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure

This trial will assess the efficacy and safety of QSG in CHF.

Beijing, Beijing Municipality, ChinaView details
TerminatedN/A

University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project

The proposed project is a 2x2 factorial designed study aimed at assessing the impact of 1) a home tele-monitoring system and 2) a flexible diuretic regimen among high risk heart failure patients in the University of Michigan Health System (

Ann Arbor, Michigan, United StatesView details
Not yet recruiting

Risk Stratification Via HF-QRS and Fibrosis Biomarkers in Heart Failure

This study aims to evaluate whether high-frequency QRS (HF-QRS) signal parameters and circulating myocardial fibrosis biomarkers (such as PIIINP, Galectin-3, and sST2) can improve risk stratification in patients with chronic heart failure (

Multiple locationsView details
TerminatedPhase 2

Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

The principal research objectives are to demonstrate cardioselective beta-blockade using bisoprolol is not inferior to placebo with regard to pulmonary function and improves quality of life in patients with heart failure and coexistent mode

Glasgow, Scotland, United KingdomView details
UnknownN/A

RV Systolic and Diastolic Function and Contractile Reserve Under Acute Exercise and in Response to Chronic Exercise-based Rehabilitation

Exercise training in Pulmonary arterial hypertension in the setting of rehabilitation leads to an enormous improvement of functional state and haemodynamics. However the underlying mechanism is still unkown.

Giessen, GermanyView details
CompletedPhase 1

Correlation Research Study: IQ2, NcIQ and IQ101

The new NcIQ thoracic impedance monitor is based on the predicate device, the IQ101. The new model uses the same 3-dimensional signal averaging as the original device, but also include second radio frequency signal to permit the device to w

Multiple locationsView details
Completed

TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics

The purpose of this study is to look at the heart rate and rhythm information collected daily in Medtronic implantable pulse generators (IPG), implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices

Mesa, Arizona, United States+97 moreView details
CompletedN/A

Integration of Chronic Disease Rehabilitation Services Into Primary Care

The aim of PR1MaC is to establish a clinical intervention that will adapt and permanently integrate rehabilitation services into primary care settings, which would be the reference point in the health care system for people with Chronic dis

Chicoutimi, Quebec, CanadaView details
RecruitingPhase 1

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF).

Bradenton, Florida, United States+2 moreView details
UnknownN/A

Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial

The purpose of this study is to investigate the effect of an early, coordinated rehabilitation intervention for patients with severe heart failure in NYHA class III and IV with a ejection fraction of \<40% of normal cardiac function measure

Copenhagen, Gentofte, DenmarkView details
Completed

V-A ECMO AUTO Mode Registry

Abiomed Impella V-A ECMO AUTO Mode - Observational Study

Aachen, North Rhine-Westphalia, Germany+5 moreView details
WithdrawnN/A

The Effects of a CONCOR Smartphone Application

Life expectancy of children with congenital heart disease (CHD) has increased dramatically during the past years, due to the successes of cardiac surgery. Nearly all of these children with CHD can be operated at young age and more than 90%

Amsterdam, NetherlandsView details
WithdrawnPhase 2

Dobutamaine Versus Milrinone in Cardiorenal Syndrome

Heart failure is recognized as one of the most common indications for hospitalization amongst adults aged \>65 years in United States with estimated Medicare cost to be 17 billion or more. Chronic heart failure is one of the most life threa

Brooklyn, New York, United StatesView details
CompletedPhase 2 / Phase 3

Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure

This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.

Durham, North Carolina, United StatesView details
CompletedN/A

ST2 for the Management of Heart Failure - STADE-HF

Heart failure (HF) is a severe disease, burdened with a poor prognosis (30% mortality at 2 years, 30% of rehospitalization within 1 month). It is also a major cause of health burden representing between 1.5 and 2 billions euros per year in

Montpellier, Languedoc-Roussillon, FranceView details
UnknownPhase 1 / Phase 2

Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

While trastuzumab has been shown to prevent recurrences of breast cancer, some women may also experience damage to their heart muscle (including heart failure) as a result of their treatment. The investigators hope to learn if standard medi

Edmonton, Alberta, CanadaView details
CompletedN/A

Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial

The purpose of the study is to determine the myocardial function and vascular adaptation after strenuous exercise in association with genotype/polymorphisms. We aim to investigate the effects of extreme endurance exercise on the cardiovascu

Munich, Bavaria, GermanyView details
Load more trials